Issue 35, 2022, Issue in Progress

Jejuketomycins A and B, polyketide glycosides with cancer cell migration inhibitory activity from Streptomyces sp. KCB15JA151

Abstract

Two new polyketide glycosides jejuketomycins A (1) and B (2), were isolated from a culture of Streptomyces sp. KCB15JA151. Their chemical structures including the absolute configurations were determined by detailed analyses of the NMR and HRMS data and ECD calculations and spectral data. Compounds 1 and 2 possess an unusual 6/6/8 tricyclic ring system. Biological evaluation with the wound healing assay and time-lapse cell tracking analysis revealed that compounds 1 and 2 have significant inhibitory activities against cancer cell migration with low cytotoxicity.

Graphical abstract: Jejuketomycins A and B, polyketide glycosides with cancer cell migration inhibitory activity from Streptomyces sp. KCB15JA151

Supplementary files

Article information

Article type
Paper
Submitted
30 Jun 2022
Accepted
30 Jul 2022
First published
10 Aug 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 22360-22366

Jejuketomycins A and B, polyketide glycosides with cancer cell migration inhibitory activity from Streptomyces sp. KCB15JA151

J. Jang, G. S. Kim, T. H. Oh, B. Park, M. Kim, G. J. Hwang, H. Lee, J. Lee, Y. Hong, J. S. Ahn, S. Ko and J. Jang, RSC Adv., 2022, 12, 22360 DOI: 10.1039/D2RA04039E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements